JP2025512468A5 - - Google Patents
Info
- Publication number
- JP2025512468A5 JP2025512468A5 JP2024560675A JP2024560675A JP2025512468A5 JP 2025512468 A5 JP2025512468 A5 JP 2025512468A5 JP 2024560675 A JP2024560675 A JP 2024560675A JP 2024560675 A JP2024560675 A JP 2024560675A JP 2025512468 A5 JP2025512468 A5 JP 2025512468A5
- Authority
- JP
- Japan
Links
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202263331733P | 2022-04-15 | 2022-04-15 | |
| US63/331,733 | 2022-04-15 | ||
| US202263368691P | 2022-07-18 | 2022-07-18 | |
| US63/368,691 | 2022-07-18 | ||
| PCT/US2023/065774 WO2023201332A1 (en) | 2022-04-15 | 2023-04-14 | Dosing of muscle targeting complexes for treating myotonic dystrophy |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2025512468A JP2025512468A (ja) | 2025-04-17 |
| JPWO2023201332A5 JPWO2023201332A5 (https=) | 2026-04-23 |
| JP2025512468A5 true JP2025512468A5 (https=) | 2026-04-23 |
Family
ID=88330392
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2024560675A Pending JP2025512468A (ja) | 2022-04-15 | 2023-04-14 | 筋緊張性ジストロフィーを処置するための筋標的化複合体の投薬 |
Country Status (10)
| Country | Link |
|---|---|
| US (1) | US20250249117A1 (https=) |
| EP (1) | EP4508092A1 (https=) |
| JP (1) | JP2025512468A (https=) |
| KR (1) | KR20250004771A (https=) |
| CN (1) | CN119343373A (https=) |
| AU (1) | AU2023252927A1 (https=) |
| CA (1) | CA3248684A1 (https=) |
| IL (1) | IL316206A (https=) |
| MX (1) | MX2024012730A (https=) |
| WO (1) | WO2023201332A1 (https=) |
Families Citing this family (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US11168141B2 (en) | 2018-08-02 | 2021-11-09 | Dyne Therapeutics, Inc. | Muscle targeting complexes and uses thereof for treating dystrophinopathies |
| US11911484B2 (en) | 2018-08-02 | 2024-02-27 | Dyne Therapeutics, Inc. | Muscle targeting complexes and uses thereof for treating myotonic dystrophy |
| EP3829595A4 (en) | 2018-08-02 | 2022-08-24 | Dyne Therapeutics, Inc. | MUSCLE-DIRECTED COMPLEXES AND USES THEREOF IN THE TREATMENT OF DYSTROPHINOPATHIES |
| US12018087B2 (en) | 2018-08-02 | 2024-06-25 | Dyne Therapeutics, Inc. | Muscle-targeting complexes comprising an anti-transferrin receptor antibody linked to an oligonucleotide and methods of delivering oligonucleotide to a subject |
| US12370264B1 (en) | 2018-08-02 | 2025-07-29 | Dyne Therapeutics, Inc. | Complexes comprising an anti-transferrin receptor antibody linked to an oligonucleotide and method of delivering oligonucleotide to a subject |
| US20220193250A1 (en) | 2018-08-02 | 2022-06-23 | Dyne Therapeutics, Inc. | Muscle targeting complexes and uses thereof for treating facioscapulohumeral muscular dystrophy |
| US12097263B2 (en) | 2018-08-02 | 2024-09-24 | Dyne Therapeutics, Inc. | Muscle targeting complexes and uses thereof for treating myotonic dystrophy |
| US11771776B2 (en) | 2021-07-09 | 2023-10-03 | Dyne Therapeutics, Inc. | Muscle targeting complexes and uses thereof for treating dystrophinopathies |
| IL309936A (en) | 2021-07-09 | 2024-03-01 | Dyne Therapeutics Inc | Muscle targeting complexes and formulations for the treatment of dystrophinopathy |
| US11969475B2 (en) | 2021-07-09 | 2024-04-30 | Dyne Therapeutics, Inc. | Muscle targeting complexes and uses thereof for treating facioscapulohumeral muscular dystrophy |
| US20250339553A1 (en) | 2022-04-15 | 2025-11-06 | Dyne Therapeutics, Inc. | Muscle targeting complexes and formulations for treating myotonic dystrophy |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| IL312067B2 (en) * | 2018-12-21 | 2025-08-01 | Avidity Biosciences Inc | Anti-transferrin receptor antibodies and uses thereof |
| AU2021318851A1 (en) * | 2020-07-23 | 2023-03-16 | Dyne Therapeutics, Inc. | Muscle targeting complexes and uses thereof for treating myotonic dystrophy |
-
2023
- 2023-04-14 KR KR1020247037614A patent/KR20250004771A/ko active Pending
- 2023-04-14 US US18/856,266 patent/US20250249117A1/en active Pending
- 2023-04-14 CN CN202380040662.9A patent/CN119343373A/zh active Pending
- 2023-04-14 JP JP2024560675A patent/JP2025512468A/ja active Pending
- 2023-04-14 IL IL316206A patent/IL316206A/en unknown
- 2023-04-14 AU AU2023252927A patent/AU2023252927A1/en active Pending
- 2023-04-14 WO PCT/US2023/065774 patent/WO2023201332A1/en not_active Ceased
- 2023-04-14 EP EP23789176.7A patent/EP4508092A1/en active Pending
- 2023-04-14 CA CA3248684A patent/CA3248684A1/en active Pending
-
2024
- 2024-10-14 MX MX2024012730A patent/MX2024012730A/es unknown